Therapeutic Advances in Adult B-cell Acute Lymphoblastic Leukemia with KMT2A Rearrangements
Shen-Hao Liu, Ai-Ni Deng, Hui-Ying Li, Kai-Wen Tan, Sheng-Li Xue, Hai-Ping Dai · 2026
Read Therapeutic Advances in Adult B-cell Acute Lymphoblastic Leukemia with KMT2A Rearrangements by Shen-Hao Liu, Ai-Ni Deng, Hui-Ying Li, Kai-Wen Tan, Sheng-Li Xue, Hai-Ping Dai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13473320.txt.
Description
Shen-Hao Liu and co-authors review new care options in 2026 for an aggressive form of B-cell leukemia in adults. In this subtype, a gene called KMT2A is broken and rejoined in a harmful way. Standard chemo plus stem cell transplant still leaves high relapse rates. The review gathers proof for antibody drugs, cell therapy, and a new class of pills called menin blockers.
Antibody drugs that link immune cells to cancer cells now help in first care and after relapse. Cell therapy made from a patient own T cells can work, though cancer may hide the target or switch type. Menin blockers attack the gene fault at its root and show early promise. The authors map where each option fits and what blocks wider use.
Catalog record
| CREATOR | Shen-Hao Liu, Ai-Ni Deng, Hui-Ying Li, Kai-Wen Tan, Sheng-Li Xue, Hai-Ping Dai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |